ZAZOVE ASSOCIATES LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 30 filers reported holding PDL BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
ZAZOVE ASSOCIATES LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2017$2,081,000
-0.2%
2,080,0000.0%0.12%
+15.0%
Q3 2017$2,085,000
+0.2%
2,080,0000.0%0.11%
-1.8%
Q2 2017$2,081,000
+0.7%
2,080,0000.0%0.11%0.0%
Q1 2017$2,067,000
+34.3%
2,080,000
+31.6%
0.11%
+49.3%
Q4 2016$1,539,0000.0%1,580,0000.0%0.07%
+2.8%
Q3 2016$1,539,000
-80.6%
1,580,000
-81.1%
0.07%
-80.7%
Q2 2016$7,913,000
-51.4%
8,340,000
-53.5%
0.37%
-52.0%
Q1 2016$16,267,000
-9.7%
17,950,000
-20.5%
0.77%
-9.3%
Q4 2015$18,016,000
+85.4%
22,590,000
+103.1%
0.85%
+88.4%
Q3 2015$9,716,000
+4.1%
11,120,000
+12.7%
0.45%
+14.0%
Q2 2015$9,333,000
-1.5%
9,870,0000.0%0.39%
-12.2%
Q1 2015$9,475,000
-25.5%
9,870,000
-25.1%
0.45%
-13.5%
Q4 2014$12,725,000
-0.7%
13,180,0000.0%0.52%
+4.4%
Q3 2014$12,811,000
-14.8%
13,180,0000.0%0.50%
-16.5%
Q2 2014$15,041,000
-26.0%
13,180,000
-31.1%
0.60%
-16.2%
Q1 2014$20,317,00019,120,0000.71%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2016
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 19,703,000$19,738,0002.83%
ASCEND CAPITAL, LLC 43,840,000$43,727,0001.65%
ZAZOVE ASSOCIATES LLC 2,080,000$2,085,0000.11%
Verition Fund Management LLC 1,000,000$1,004,0000.08%
OAKTREE CAPITAL MANAGEMENT LP 4,940,000$4,940,0000.07%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 3,420,000$3,424,0000.05%
UBS ASSET MANAGEMENT AMERICAS LLC 37,800,000$37,702,476,0000.03%
Sterneck Capital Management, LLC 18,000$18,0000.01%
ADVENT CAPITAL MANAGEMENT /DE/ 235,000$212,0000.00%
INVESTMENT CENTERS OF AMERICA INC 50,000$50,0000.00%
View complete list of PDL BIOPHARMA INC shareholders